Eric Curtis

Eric Curtis

Chief Operating Officer en WINDTREE THERAPEUTICS, INC. .

Fortuna: 5 636 $ al 31/03/2024

56 años
Health Technology
Consumer Services
Health Services

Perfil

Eric L.
Curtis
currently works at Windtree Therapeutics, Inc., as Chief Operating Officer & Senior Vice President from 2020.
Mr. Curtis also formerly worked at Centurion BioPharma Corp., as President & Chief Executive Officer, LadRx Corp., as President & Chief Operating Officer from 2018 to 2020, Aegerion Pharmaceuticals, Inc., as President-US Commercial from 2014 to 2016, and Bayer HealthCare, as Vice President & General Manager-Rare Disease from 2012 to 2014.
Mr. Curtis received his undergraduate degree from the University of Pittsburgh and Masters Business Admin degree in 1999 from The Pennsylvania State University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
16/04/2024 15 920 ( 0.19% ) 5 636 $ 31/03/2024

Cargos activos de Eric Curtis

EmpresasCargoInicio
WINDTREE THERAPEUTICS, INC. Chief Operating Officer 09/03/2020
Todos los cargos activos de Eric Curtis

Antiguos cargos conocidos de Eric Curtis.

EmpresasCargoFin
LADRX CORPORATION President 08/03/2020
AEGERION PHARMACEUTICALS, INC. Corporate Officer/Principal 01/01/2016
Corporate Officer/Principal 01/01/2014
Centurion BioPharma Corp. Chief Executive Officer -
Ver el detalle de la experiencia de Eric Curtis.

Formación de Eric Curtis.

University of Pittsburgh Undergraduate Degree
The Pennsylvania State University Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Eric Curtis.

Relaciones

100 +

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
LADRX CORPORATION

Health Technology

WINDTREE THERAPEUTICS, INC.

Health Technology

Empresas privadas3

Health Technology

Health Services

Centurion BioPharma Corp.

Ver las conexiones de la empresa